Zobrazeno 1 - 10
of 13
pro vyhledávání: ''
Autor:
Anders Heiervang Tennøe, Cathrine Brunborg, Øyvind Midtvedt, Trond Mogens Aaløkken, Øyvind Molberg, Thor Ueland, Pål Aukrust, May Britt Lund, Anna-Maria Hoffmann-Vold, Torhild Garen, Aurelija Abraityte
Publikováno v:
Chest. 150:299-306
Markers for early identification of progressive interstitial lung disease (ILD) in systemic sclerosis (SSc) are in demand. Chemokine CCL18, which has been linked to pulmonary inflammation, is an interesting candidate, but data have not been consisten
Autor:
Geertje M. de Boer, Leon M. van den Toorn, Peter Th. W. van Hal, Carla E. M. Hollak, Rogier A.S. Hoek, Michael A. den Bakker, Dennis A. Hesselink, Laura van Dussen
Publikováno v:
Chest. 149:e1-e5
Gaucher disease (GD), a lysosomal storage disorder, may result in end-stage lung disease. We report successful bilateral lung transplantation in a 49-year-old woman with GD complicated by severe pulmonary hypertension and fibrotic changes in the lung
Autor:
Thomas K. Waddell, Marco Mura, Shaf Keshavjee, Lianne G. Singer, Mingyao Liu, John Granton, Karen McRae, Masaki Anraku, Zhihong Yun, Marc de Perrot
Publikováno v:
Chest. 141:661-673
Background Pulmonary hypertension (PH) associated with pulmonary fibrosis (PF) is a severe condition with poor outcome. It is unknown whether patients with PF with associated PH (APH) represent a distinct phenotype of the disease. We hypothesized tha
Publikováno v:
Chest. 131:874-879
Chronic lung diseases like COPD, severe progressive pulmonary hypertension (PH), and interstitial lung diseases all have a lung vascular disease component. Cellular and molecular mechanisms of pulmonary vascular remodeling have been experimentally ex
Autor:
Masanori Kitaichi, Shigeru Tanaka, Michiaki Mishima, Tomohiro Handa, Takateru Izumi, Taishi Nagao, Michio Shigematsu, Kunio Hamada, Sonoko Nagai
Publikováno v:
Chest. 131:650-656
To evaluate the long-term clinical course of patients with idiopathic pulmonary fibrosis (IPF) complicated with pulmonary arterial hypertension.Prospective analysis of consecutive IPF patients undergoing initial workup with right-heart catheterizatio
Autor:
Marshall S. Riley, Janos Porszasz, Mariëlle P.K.J. Engelen, Karlman Wasserman, Bruce H. Brundage, Joe Miranda
Publikováno v:
Scopus-Elsevier
Nitric oxide (NO), a potent vasodilator, is present in the exhaled air of humans. We wished to quantify NO production in patients with abnormalities of the pulmonary circulation.Nine patients with primary pulmonary hypertension (PPH), six with pulmon
Publikováno v:
Chest. 102:1645-1650
We performed a morphometric analysis of peribronchiolar and perivascular fibrosis in lungs obtained at autopsy from six patients with chronic bronchitis, six with pulmonary emphysema, and four normal control subjects. The areas of fibrosis outside th
Autor:
Vincent Cottin, Jean-François Cordier
Publikováno v:
Chest
Chest, American College of Chest Physicians, 2009, 136 (1), pp.1-2. ⟨10.1378/chest.09-0538⟩
Chest, American College of Chest Physicians, 2009, 136 (1), pp.1-2. ⟨10.1378/chest.09-0538⟩
Combined pulmonary fibrosis and emphysema (CPFE) is a recently identified syndrome occurring almost exclusively in smokers or ex-smokers, characterized by severe dyspnea and limitation to exercise capacity. Tobacco smoking is the main etiologic facto
Publikováno v:
Chest. 128:601S
Autor:
John A. Phillips, Kirk B. Lane, James E. Loyd, Jennifer Carneal, Alan Q. Thomas, Cheryl Markin
Publikováno v:
Chest. 121:25S